We provide integrated services across:
Apr 11, 2025
What technology areas can we support?
We provide integrated services across:
- Autologous and allogeneic cell therapies (e.g. T cells, iPSCs, MSCs)
- Viral vectors (e.g. AAV, lentivirus, including scalable suspension processes)
- RNA technologies (e.g. mRNA, saRNA, cRNA with LNP encapsulation) We support process development, tech transfer, GMP manufacturing, and fill finish for these modalities within a single site.
Latest News

eXmoor Pharma and Signadori Bio launch partnership to develop next-generation monocyte-based cell therapy for solid tumours
Jun 17, 2025

Scaling Gene Therapy Production: From Bench to Clinic
May 30, 2025

eXmoor Pharma and KU Leuven announce strategic partnership to accelerate cell and gene therapy innovation through new venture
May 13, 2025
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.